Product Description
| Cat Number | KS-110 |
|---|---|
| Category | Peptide |
| Pack Size | 1 mg |
| Description | Cell permeable protein kinase A inhibitor |
| Modification | Myristoyl at N terminal, amide at C terminal |
| Purity | >95% by HPLC |
| Biomarker Target | Kinases |
| Sequence Three Letter Code | Myr-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH2 |
| Molecular Formula | C53H100N20O12 |
| Sl Sequence | Myr-GRTGRRNAI-NH2 |
| Solubility | Soluble in dilute acid and DMSO as a stock solution. |
| Appearance | Freeze dried solid |
| Storage | Store desiccated, frozen and in the dark |
| References |
Glass et al (1989) Primary structural determinants essential for potent inhibition of cAMP-dependent protein kinase by inhibitory peptides corresponding to the active portion of the heat-stable inhibitory protein. J.Biol.Chem. 264 8802 PMID: 2722799Farrow et al (2003) Inhibition of pancreatic cancer cell growth and induction of apoptosis with novel therapies directed against protein kinase A. Surgery 134 197 PMID: 12947318Liao et al (2011) Myristoylated peptides potentiate the funny current I(f) in sinoatrial myocytes. Channels 5(2) 115 doi:10.4161/chan.5.2.14195 Related areasAll cell penetrating peptides >All kinase modulators >All cancer research categories > |
| Note | The product is for research use only |
Share Item: